Applied Therapeutics, Inc. - Common Stock (APLT)

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / Common Stock
Shares outstanding
143,223,667
Total 13F shares
4,991,742
Share change
+2,593,850
Total reported value
$136,175,281
Price per share
$27.28
Number of holders
45
Value change
+$71,201,517
Number of buys
40
Number of sells
4

Institutional Holders of Applied Therapeutics, Inc. - Common Stock (APLT) as of Q4 2019

As of 31 Dec 2019, Applied Therapeutics, Inc. - Common Stock (APLT) was held by 45 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,991,742 shares. The largest 10 holders included ORBIMED ADVISORS LLC, EMERALD MUTUAL FUND ADVISERS TRUST, Knoll Capital Management, LP, ALKEON CAPITAL MANAGEMENT LLC, Perella Weinberg Partners Capital Management LP, VANGUARD GROUP INC, BlackRock Inc., FMR LLC, Artisan Partners Limited Partnership, and ACUTA CAPITAL PARTNERS, LLC. This page lists 45 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.